Back to results
US 2010/0143977 A1Published application
Genetically modified strains producing anthracycline metabolites useful as cancer drugs
AssigneeW.C. Heraeus GmbH
InventorsMichael Lambert, Kristiina Ylihonko
Life of this patent
Estimating the term…
Abstract
The invention refers to a microbial strain, which produces anthracycline metabolites at a titre of at least 0.5 g/l fermentation broth.
Claims19
A microbial strain that produces anthracycline metabolites at a titre of at least 0.5 g/l fermentation broth.
Dependencies are inferred from the claim text.